Yan Ding

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Top Venues

OncoTargets and therapy

Nature communications

Chaos (Woodbury, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Pushpanathan Muthuirulan, Dewei Zhao, Mariel Young, Daniel Richard, Zun Liu, Alireza Emami, Gabriela Portilla, Shayan Hosseinzadeh, Jiaxue Cao, David Maridas, Mary Sedlak, Danilo Menghini, Liangliang Cheng, Lu Li, Xinjia Ding, Yan Ding, Vicki Rosen, Ata M Kiapour, Terence Dante Capellini
Author Correction: Joint disease-specificity at the regulatory base-pair level. Nature communications 13 (1) (2022)
Xinjia Ding, Jianguo Zong, Xiang Li, Xiaoyan Bai, Bowen Tan, Weibing Sun, Ruoyu Wang, Yan Ding
Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report. OncoTargets and therapy 14 (2021)
Pushpanathan Muthuirulan, Dewei Zhao, Mariel Young, Daniel Richard, Zun Liu, Alireza Emami, Gabriela Portilla, Shayan Hosseinzadeh, Jiaxue Cao, David Maridas, Mary Sedlak, Danilo Menghini, Liangliang Cheng, Lu Li, Xinjia Ding, Yan Ding, Vicki Rosen, Ata M Kiapour, Terence Dante Capellini
Joint disease-specificity at the regulatory base-pair level. Nature communications 12 (1) (2021)
Tong Zhao, Yuqin Tian, Xinjia Ding, Lin Liu, Bowen Tan, Bin Yang, Jianlin Wu, Ting Lei, Ruoyu Wang, Yan Ding
Genetic Analysis and Targeted Therapy Using Buparlisib and MK2206 in a Patient with Triple Metachronous Cancers of the Kidney, Prostate, and Squamous Cell Carcinoma of the Lung: A Case Report. OncoTargets and therapy 14 (2021)
Yan Ding, Hongsheng Xue, Xinjia Ding, Yuqing Zhao, Zhilong Zhao, Dazhi Wang, Jianlin Wu
On the complexity measures of mutation hotspots in human TP53 protein. Chaos (Woodbury, N.Y.) 30 (7) (2021)